BMP4 and metabolic dysfunction-associated steatotic liver disease: We found that BMP4 expression was elevated during the development of mouse model of NAFLD, whereas exogenous BMP4 was shown to inhibit hepatic triglyceride/lipid accumulation by promoting lipid turnover and by suppressing the mTORC1 signaling pathway.